02
Nov
2009
Posted in I - Series A, Q - 3Q09, R - INTERNATIONAL, X - Device (Renal)
Quanta Fluid Solutions (United Kingdom) a development-stage medical device company focused on haemodialysis systems for acute renal failure, has closed a $14.3M Series A financing. Participants include NBGI Ventures, Seroba Kernel Life Sciences, Wellington Partners Venture Capital and Brains-To-Ventures.